§ EQUITY
USDAGMB
AGOMAB THERAPEUTICS NV
USD
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
ANALYST
13 buy, 1 hold, 0 sell
Finnhub
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| EQT Fund Management S.a r.l. | 5.1M | 5.3% | n/a |
| Sanofi | 2.8M | 8.7% | n/a |
| Cormorant Asset Management, LP | 2.5M | 1.3% | n/a |
| TCG Crossover Management, LLC | 2.1M | 0.6% | n/a |
| FEDERATED HERMES, INC. | 1.6M | 0.0% | n/a |
| Casdin Capital, LLC | 1.6M | 1.2% | n/a |
◇ AC INTELLIGENCE
Top institutional owners for AGMB as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER83.4% · 23 holders
QUALITY / COMPOUNDER15.8% · 3 holders
TACTICAL / MACRO0.5% · 2 holders
DEALER / BANK0.2% · 3 holders
ACTIVIST0.1% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for AGMB in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention AGMB yet.